Literature DB >> 8450573

Decline in intravenous drug use among treatment-seeking opiate users.

R S Schottenfeld1, S O'Malley, K Abdul-Salaam, P G O'Connor.   

Abstract

Opiate users seeking treatment during similar time periods in 1986 (n = 60) and 1988 (n = 82) did not differ significantly with regard to demographic factors, length of addiction, use of cocaine, history of alcohol problems, or indices of depression. In 1988, however, users reported significantly lower rates of current intravenous drug use than was reported in 1986: 39% in 1988, compared to 14% in 1986, reported not currently using IV (chi 2(1, N = 142) = 11.302, p < .001). For the combined periods, current IV users (n = 102) did not differ significantly from those who were not currently using IV (n = 40) with regard to demographic factors, size of habit, history of alcohol problems, or indices of depression. Current IV users had used opiates longer (mean 11.3 years versus 8.4 years; t(1, 65) = 2.20, p < .03), and there was a trend for cocaine use to be associated with current IV administration. For the smaller subset of those who survived waiting lists of between 1 to 4 months from the time of intake to program admission and physical examination (n = 81), 35% (6/17) of those who were not IV drug users at the time of clinic intake reported resuming or initiating IV drug use by the time of program admission. The validity of self-reports of not using IV at the time of program admission was assessed by comparison of self-report with findings of track marks on physical examination: inconsistencies were detected in 11% (1/9) of those whose self-reports indicated no current IV use.

Entities:  

Mesh:

Year:  1993        PMID: 8450573     DOI: 10.1016/0740-5472(93)90092-g

Source DB:  PubMed          Journal:  J Subst Abuse Treat        ISSN: 0740-5472


  12 in total

1.  Illicit opioid use in Canada: comparing social, health, and drug use characteristics of untreated users in five cities (OPICAN study).

Authors:  Benedikt Fischer; Jürgen Rehm; Suzanne Brissette; Serge Brochu; Julie Bruneau; Nady El-Guebaly; Lina Noël; Mark Tyndall; Cameron Wild; Phil Mun; Dolly Baliunas
Journal:  J Urban Health       Date:  2005-05-04       Impact factor: 3.671

2.  Individual and system influences on waiting time for substance abuse treatment.

Authors:  Carey J A Carr; Jiangmin Xu; Cristina Redko; D Timothy Lane; Richard C Rapp; John Goris; Robert G Carlson
Journal:  J Subst Abuse Treat       Date:  2007-05-23

3.  From Long-Term Injecting to Long-Term Non-Injecting Heroin and Cocaine Use: The Persistence of Changed Drug Habits.

Authors:  Don C Des Jarlais; Kamyar Arasteh; Jonathan Feelemyer; Courtney McKnight; David M Barnes; Susan Tross; David C Perlman; Aimee N C Campbell; Hannah L F Cooper; Holly Hagan
Journal:  J Subst Abuse Treat       Date:  2016-08-21

4.  Can intranasal drug use reduce HCV infection among injecting drug users?

Authors:  Don C Des Jarlais; Holly Hagan; Kamyar Arasteh; Courtney McKnight; Salaam Semaan; David C Perlman
Journal:  Drug Alcohol Depend       Date:  2011-07-26       Impact factor: 4.492

Review 5.  Group sex events amongst non-gay drug users: an understudied risk environment.

Authors:  Samuel R Friedman; Pedro Mateu-Gelabert; Milagros Sandoval
Journal:  Int J Drug Policy       Date:  2010-08-25

6.  Self-efficacy estimates for drug use practices predict risk reduction among injection drug users.

Authors:  David D Celentano; Sylvia Cohn; Richard O Davis; David Vlahov
Journal:  J Urban Health       Date:  2002-06       Impact factor: 3.671

7.  Heroin and cocaine co-use in a group of injection drug users in Montréal.

Authors:  Francesco Leri; Jane Stewart; Annie Tremblay; Julie Bruneau
Journal:  J Psychiatry Neurosci       Date:  2004-01       Impact factor: 6.186

Review 8.  Methadone maintenance treatment: an update.

Authors:  G Bertschy
Journal:  Eur Arch Psychiatry Clin Neurosci       Date:  1995       Impact factor: 5.270

9.  Transitions from injecting to non-injecting drug use: potential protection against HCV infection.

Authors:  Don C Des Jarlais; Courtney McKnight; Kamyar Arasteh; Jonathan Feelemyer; David C Perlman; Holly Hagan; Hannah L F Cooper
Journal:  J Subst Abuse Treat       Date:  2013-10-23

Review 10.  Meta-analysis of depression and substance use and impairment among intravenous drug users (IDUs).

Authors:  Kenneth R Conner; Martin Pinquart; Paul R Duberstein
Journal:  Addiction       Date:  2008-02-04       Impact factor: 6.526

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.